Testing blood donations for markers of infectious disease is critical to the maintenance of blood safety. The minimal expectation from WHO is that all donations should be tested for HIV, HBV, HCV and syphilis and that, in certain parts of the world, it may be appropriate to test for locally prevalent transfusion‐transmissible infectious (TTI) agents. This article will review the rationale for selection of appropriate test methods and properties and will explain why there continues to be residual risk of transmission and how to estimate such risk.
No takes yet. Share an insight, caveat, or question.
Roger Y. Dodd (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: